31Jul 2017

THE PLEIOTROPIC EFFECTS OF CURCUMIN.

  • Junior Resident, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER) ,Puducherry, India.
  • Assistant Professor, Department of Clinical Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER) ,Puducherry, India.
  • Professor(Senior Scale) and Head, Department of Clinical Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER) ,Puducherry, India.
Crossref Cited-by Linking logo
  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Recently, many natural substances have been increasingly found to have significant biological properties which make them useful in the treatment of various diseases. Nature has plenty of healing properties which makes it invaluable for its role towards promotion of a healthy world. Turmeric (Curcuma longa), one of the frequently used spices in Indian cooking, is renowned for its medicinal properties from time immemorial. It is well known to possess anti inflammatory, anti oxidant, antiseptic and anti cancer properties with an excellent safety profile. The active principles of this spice are curcumin, demethoxycurcumin and bisdemethoxycurcumin. From preclinical studies to clinical trials, tremendous progress has been made with respect to this compound in the medical field .This review will focus on the effects of curcumin and its mechanisms of action in various disease conditions.

  1. Milobedzka J, Kostanecki S, Lampe V. ZurKenntnis des Curcumins. Deut. Chem. Ges.1910;43:2163?70
  2. Srinivasan KR. A chromatographic study of the curcuminoids in Curcuma longa, L.?J Pharm Pharmacol.1953;5:448?57.
  3. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.Altern Med Rev?2009 ;14:141-53
  1. Jim?nez‐Osorio AS, Monroy A, Alavez S. Curcumin and insulin resistance?Molecular targets and clinical evidences. BioFactors. 2016 Jun 21.
  2. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular cancer. 2011 ;10:12
  3. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem. 1995 Oct ;270:24995-5000.
  4. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research. 2008 ;14:4491-9.
  5. Montgomery A, Adeyeni T, San K, Heuertz RM, Ezekiel UR. Curcumin Sensitizes Silymarin to Exert Synergistic Anticancer Activity in Colon Cancer Cells.J Cancer.?2016 ;7:1250-7
  6. Tsai J-R, Liu P-L, Chen Y-H, Chou S-H, Cheng Y-J, Hwang J-J, et al. CurcuminInhibitsNon-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-κb/MMPs Signaling Pathway. PLoS One 2015;10:e0144462.
  7. Huang TY, Hsu CW, Chang WC, Wang MY, Wu JF, Hsu YC. Demethoxycurcumin retards cell growth and induces apoptosis in human brain malignant glioma GBM 8401 cells. Evid Based Complement Alternat Med. 2012 Feb 15;2012.
  8. Senft C, Polacin M, Priester M, Seifert V, K?gel D, Weissenberger J. The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer. 2010;10:491.
  9. Gomez-Bougie P, Halliez M, Ma?ga S, Godon C, Kervo?len C, Pellat-DeceunynckC,et al. Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups. Cancer BiolTher. 2015 ;16:60-5.
  10. Javvadi P, Segan AT, Tuttle SW, Koumenis C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. MolPharmacol. 2008;73:1491-501.
  11. Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res. 2013;180:34-43.
  12. Orr WS, Denbo JW, Saab KR, Ng CY, Wu J, Li K,et al. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity. PLoS One. 2013;8:e51309.
  13. Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, Chauhan SC. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res. 2010 ;3:11.
  14. Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W,et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PloS one. 2012 ;7:e28784.
  15. Di Pierro F, Bressan A, Ranaldi D, Rapacioli G, Giacomelli L, Bertuccioli A. Potential role of bioavailable curcumin in weight loss and omental adipose tissue decrease: Preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study. Eur Rev Med Pharmacol Sci. 2015 ;19:4195-202.
  16. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes care. 2012;35:2121-7.
  17. Weisberg SP, Leibel R, Tortoriello DV. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology. 2008;149:3549-58.
  18. Usharani P, Mateen AA, Naidu MUR, Raju YSN, Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus. Drugs in R & D. 2008 ;9:243-50.
  19. Alwi I, Santoso T, Suyono S, Sutrisna B, Suyatna FD, Kresno SB, et al. The effect of curcumin on lipid level in patients with acute coronary syndrome.Acta Med Indones. 2008 ;40:201-10.
  20. Antiga E, Bonciolini V, Volpi W, Del Bianco E, Caproni M. Oral Curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris. BioMed research international. 2015 May 18;2015.
  21. Michalak-Stoma A, Bartosińska J, Kowal M, Juszkiewicz-Borowiec M, Gerkowicz A, Chodorowska G. Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. Dis Markers. 2013;35:625-31.
  22. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005;174:3695-702.
  23. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, ChootipC,et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study.Clin Interv Aging. 2014;9:451-8.
  24. http://www.rheumatology.org/I-Am-A/Rheumatologist/Research/Clinician-Researchers/Western-Ontario-McMaster-Universities-Osteoarthritis-Index-WOMAC, last accessed on 2016 august 22
  25. Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Cesarone MR, et al. Meriva?+ Glucosamine versus Condroitin+ Glucosamine in patients with knee osteoarthritis: an observational study. Eur Rev Med Pharmacol Sci. 2014;18:3959-63.
  26. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J ClinOncol. 1984;2:187-93.
  27. Lev-Ari S, Strier L, Kazanov D, Elkayam O, Lichtenberg D, Caspi D, et al. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology(Oxford). 2006;45:171-7.
  28. Hirth A, Skapenko A, Kinne RW, Emmrich F, Schulze-Koops H, Sack U. Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis. Arthritis Res. 2002;4:117-25.
  29. Xiao Z, Zhang A, Lin J, Zheng Z, Shi X, Di W, et al.Telomerase: a target for therapeutic effects of curcumin and a curcumin derivative in Aβ1-42 insult in vitro.PLoS One. 2014;9:e101251.
  30. Dutta K, Ghosh D, BasuA.Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system.JNeuroimmunePharmacol. 2009;4:328-37
  31. Swarup V, Das S, Ghosh S, BasuA.Tumor necrosis factor receptor-1-induced neuronal death by TRADD contributes to the pathogenesis of Japanese encephalitis.JNeurochem. 2007;103:771-83
  32. Wang MS, Boddapati S, Emadi S, Sierks MR. Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neurosci. 2010 ;11:57.
  33. Singla V, Mouli VP, Garg SK, Rai T, Choudhury BN, Verma P, et al. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis?a randomized, placebo-controlled, pilot study.JCrohns Colitis. 2014 ;8:208-14.
  34. Deshmukh RA, Bagewadi AS. Comparison of effectiveness of curcumin with triamcinolone acetonide in the gel form in treatment of minor recurrent aphthous stomatitis: A randomized clinical trial. Int J Pharm Investig. 2014;4:138.
  35. Jagetia GC, Aggarwal BB. ?Spicing up? of the immune system by curcumin. J ClinImmunol 2007;27:19?35.
  36. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor κB in inflammatory bowel disease. Gut. 1998 ;42:477-84.
  37. Lappas M, Permezel M, Georgiou HM, Rice GE. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. BiolReprod. 2002 ;67:668-73.
  38. Ferreira VH, Nazli A, Dizzell SE, Mueller K, Kaushic C. The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2. PloS One. 2015 ;10:e0124903.
  39. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, et al.Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation.?PLoSPathog. 2010;6:e1000852
  40. Nazli A, Kafka JK, Ferreira VH, Anipindi V, Mueller K, Osborne BJ, et al.HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium.?J Immunol. 2013;191:4246?58.
  41. Nehra S, Bhardwaj V, Ganju L, Saraswat D. Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis. PloS One.2015 ;10:e0139121.
  42. Dayton A, Selvendiran K, Meduru S, Khan M, Kuppusamy ML, Naidu S, et al. Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867. J PharmacolExpTher. 2011;339:350-7
  43. Abidi A, Gupta S, Agarwal M, Bhalla HL, Saluja M. Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma. J ClinDiagn Res: 2014;8:HC19-HC24.
  44. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, et al. Modulation of ?arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase. Carcinogenesis. 2004;25:1671-9.
  1. Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.Clin Ophthalmol. 2010;4:1201-6.
  2. Jacob A, Wu R, Zhou M, Wang P. Mechanism of the anti-inflammatory effect of curcumin: PPAR-γ activation. PPAR Res. 2007;2007:89369
  3. Bernardo A, Minghetti L. Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists. PPAR Res. 2008;2008:864140
  1. Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. 2014;28:579-85.
  2. Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord. 2014 ;167:368-75.
  3. Yu ZF, Kong LD, Chen Y. 2002. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol 83: 161?165.
  4. Wang R, Xu Y, Wu HL, Li YB, Li YH, Guo JB, et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT 1 and 5-HT 2 receptors. Eur J Pharmacol. 2008;578:43-50.

[Akila Srinivasan, Sandhiya Selvarajan and Steven Aibor Dkhar. (2017); THE PLEIOTROPIC EFFECTS OF CURCUMIN. Int. J. of Adv. Res. 5 (Jul). 2749-2756] (ISSN 2320-5407). www.journalijar.com

Dr Akila S
Junior Resident, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER) ,Puducherry, India

DOI:

Article DOI: 10.21474/IJAR01/5020      
DOI URL: http://dx.doi.org/10.21474/IJAR01/5020

Download Full Paper

Download PDF No. of Downloads: 55 | No. of Views: 215